To: All persons and/or entities who purchased common stock (including through the exercise of warrants or options) and/or call options, and/or sold publicly traded put options in Spectrum Pharmaceuticals, Inc. [SPPI] during the period from August 8, 2012 to March 12, 2013, and were damaged thereby; a settlement has been announced in the securities litigation known as In re: Spectrum Pharmaceuticals, Inc., Securities Litigation, Civil Action No. 2:13-cv-00433-LDG, United States District Court for the District of Nevada. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below):
Claim submission deadline is June 9, 2016.
If you have any questions about the settlement, please contact the Claims Administrator. Their contact information can be found in the attached Notice.
Contact Us for
10205 North Pennsylvania Avenue, Oklahoma City, Oklahoma 73120Ph: 405.235.1560 Fax: 405.239.2112
Copyright © 2017 Federman & Sherwood. All Rights Reserved.